Cita APA

Nishikawa, R., Nagane, M., Shimizu, A., Tamura, T., & Ura, M. (2017). ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS. Neuro Oncol.

Citación estilo Chicago

Nishikawa, Ryo, Motoo Nagane, Ayaka Shimizu, Takashi Tamura, y Masako Ura. "ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS." Neuro Oncol 2017.

Cita MLA

Nishikawa, Ryo, et al. "ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS." Neuro Oncol 2017.